CoChat
Sign Up
Cited by 125Posttraumatic Stress Disorder ResearchPsychotherapy Techniques and ApplicationsSleep and related disorders

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD

Open access
Zoellner, Lori A., Roy-Byrne, Peter P., Mavissakalian, Matig, Feeny, Norah C.·2019·American Journal of Psychiatry
DOI 10.1176/appi.ajp.2018.17090995
Open this paper in CoChat — free accountOpen PDF

Abstract

OBJECTIVE: The authors examined the effect of patient treatment preference on the differential effectiveness of prolonged exposure and sertraline for the treatment of posttraumatic stress disorder (PTSD). METHOD: In a doubly randomized preference trial, 200 patients with PTSD viewed standardized treatment rationales prior to randomization. Patients were first randomized to choice of treatment or no choice. Those assigned to no choice were then randomized to prolonged exposure or sertraline. Acute treatment was 10 weeks, with 24-month follow-up. Interviewer-rated PTSD symptom severity was the main outcome measure, and depression, anxiety, and functioning were assessed as additional outcomes. RESULTS: Patients preferred prolonged exposure over sertraline (number needed to benefit [NNTB]=4.5). Using intent-to-treat analyses (N=200), both prolonged exposure and sertraline showed large gains that were maintained over 24 months. Although no differential effect was observed on interviewer-rated PTSD severity, there was a significant benefit of prolonged exposure over sertraline on interview-rated loss of PTSD diagnosis (NNTB=7.0), responder status (NNTB=5.7), and self-reported PTSD, depression, and anxiety symptoms and functioning (effect sizes, 0.35-0.44). Patients who received their preferred treatment were more likely to be adherent, lose their PTSD diagnosis (NNTB=3.4), achieve responder status (NNTB=3.4), and have lower self-reported PTSD, depression, and anxiety symptoms (effect sizes, 0.40-0.72). CONCLUSIONS: Prolonged exposure and sertraline confer significant benefits for PTSD, with some evidence of an advantage for prolonged exposure. Giving patients with PTSD their preferred treatment also confers important benefits, including enhancing adherence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2018.17090995

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 28 references

Research works printed but not linked: 3

  1. Institute of Medicine, 2007, Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence
  2. First MB, 1995, Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P)
  3. Sheehan DV, 1983, The Anxiety Disease

Cited by

Sorted by citations

Items 101–125 of 125

Related

See all

Metadata

Authors
Zoellner, L. A., Roy-Byrne, P. P., Mavissakalian, M., & Feeny, N. C.
Affiliations
  • University of Washington (US)
  • From the Department of Psychology and the Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle; and the Department of Psychiatry and the Department of Psychology, Case Western Reserve University, Cleveland.
ORCID
Venue
American Journal of Psychiatry
Publisher
American Psychiatric Association Publishing
Published
2019-04-01
Volume
176
Issue
4
Pages
287-296
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
DOI
10.1176/appi.ajp.2018.17090995
OpenAlex
W2896074510
Cited by
125
References
28
Citations by year
2026: 8 · 2025: 8 · 2024: 19 · 2023: 15 · 2022: 23 · 2021: 14 · 2020: 21 · 2019: 13
FWCI
14.66
Type
journal article
Language
en
Open access
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Mental Health (R01MH066348, R01MH066347)
  • National Center for Research Resources (UL1RR024989)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
post-traumatic stress disorder, prolonged exposure, sertraline, patient treatment preferences, medication adherence, psychotherapy versus pharmacotherapy, depression, anxiety, functional outcome, long-term follow-up
MeSH terms
Adult, Female, Humans, Implosive Therapy, Male, Stress Disorders, Post-Traumatic, Selective Serotonin Reuptake Inhibitors, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review